Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-01 Sale | 2023-11-03 4:39 pm | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 21,619 | $13.84 | $299,309 | 1,538,070 (Indirect Direct) | View |
| 2023-10-02 Sale | 2023-10-04 5:07 pm | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 20,245 | $14.82 | $300,026 | 1,559,689 (Indirect Direct) | View |
| 2023-05-16 Sale | 2023-05-18 5:22 pm | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 15,000 | $19.98 | $299,700 | 1,579,934 (Indirect Direct) | View |
| 2023-05-11 Sale | 2023-05-15 8:34 pm | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 45,000 | $20.68 | $930,656 | 1,594,934 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-28 Tax Withholding | 2024-03-01 4:40 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner | 2,119 | $6.27 | 1,453,244 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:44 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner | 12,950 | $0 | 1,455,363 (Direct) | View |
| 2024-02-27 Tax Withholding | 2024-02-29 4:44 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner | 3,154 | $6.44 | 1,455,363 (Direct) | View |
| 2024-01-05 Tax Withholding | 2024-01-09 5:00 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner | 4,322 | $5.13 | 1,533,748 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:18 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 70,900 | $0 | 1,639,934 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-02 4:18 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 3,113 | $28 | 1,639,934 (Direct) | View |
| 2023-01-23 Tax Withholding | 2023-01-24 6:13 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 3,732 | $33.64 | 1,572,147 (Direct) | View |
| 2023-01-05 Tax Withholding | 2023-01-09 4:33 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 3,827 | $29.26 | 1,575,879 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 6:02 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 34,800 | $0 | 1,579,706 (Direct) | View |
| 2021-02-23 Gift | 2021-04-05 4:54 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 16,340 | $0 | 1,544,906 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-05 4:54 pm | N/A 2021-05-02 | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 31,201 | $0 | 1,544,906 (Direct) | View |
| 2021-04-01 Tax Withholding | 2021-04-05 4:54 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 16,278 | $41.87 | 1,544,906 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-05 4:54 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 31,201 | $8.78 | 1,544,906 (Direct) | View |
| 2021-01-23 Tax Withholding | 2021-01-26 6:31 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 4,631 | $47.7 | 1,546,323 (Direct) | View |
| 2020-01-23 Tax Withholding | 2020-01-27 4:17 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 7,548 | $57.98 | 1,550,954 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:29 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 204,000 | $0 | 1,704,202 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-03 5:11 pm | N/A 2029-12-31 | ZIOPHARM ONCOLOGY INC | ZIOP | Tarriff Scott Director | 50,562 | $0 | 50,562 (Direct) | View |
| 2019-12-04 Option Award | 2019-12-06 07:13 am | 2019-12-04 2026-12-04 | Synthetic Biologics Inc. | SYN | Tarriff Scott Director | 250,000 | $0 | 250,000 (Direct) | View |